second half News
Most Popular second half Story
Migenix cuts costs to stretch cash
Canada's Migenix is cutting its staff in an effort to preserve cash. The company, which is developing the anti-infective drug Omigard, cut six workers, reduced its CEO's salary and downsized its... Read more...
Latest Headlines
- May 27, 2008
- April 7, 2008
- March 3, 2008
- December 6, 2007
- November 13, 2007
- August 9, 2007
- November 16, 2006
- June 11, 2006
- April 2, 2006
- March 28, 2006
- March 27, 2006
- January 11, 2006
- January 11, 2006
- June 8, 2005
- June 7, 2005
- June 6, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
